Life Sciences Industry News
-
SEC adopts McAdams and Hollingsworth proposal to cut red tape on promising start-ups
Courtesy of mcadams.house.gov Washington, D.C.—Legislation by Congressman Ben McAdams and Congressman Trey Hollingsworth (R-IN) giving commonsense regulatory relief…
-
BioUtah COVID-19 Life Sciences Survey
TIME SENSITIVE – PLEASE TAKE SURVEY Dear Members of Utah’s Life Sciences Community, BioUtah is taking a multi-pronged approach…
-
The Department of Health and Human Services on PREP
The Department of Health and Human Services issued a declaration on March 16 under the Public Readiness and…
-
BioUtah Statement & Recommendations to Members on COVID-19
The advent and progression of the Novel Coronavirus, COVID-19, pandemic requires a proper and measured response from every…
-
PRESIDENT TRUMP SIGNS $8.3 BILLION CORONAVIRUS FUNDING BILL
Today, President Trump sign a $8.3 billion emergency coronavirus funding measure, after it cleared both the House and…
-
Co-Diagnostics, Inc. Invited to Speak on Coronavirus at Molecular Med Tri-Con in San Francisco
March 03, 2020 06:30 AM Eastern Standard Time SALT LAKE CITY–(BUSINESS WIRE)–Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics…
-
BioUtah and the TVC Announce Keynote Speakers for the 2020 E & I Life Science Summit
Founder and CEO of Tolero Pharmaceuticals, David Bearss, Ph.D, and Managing Director and Head of Global Investment Opportunities…
-
ABC 4 Utah Features E&I Summit
ABC 4’s Good Morning Utah featured the 2020 Entrepreneur & Investor Summit this morning, sitting down with Keith Marmer,…
-
BioUtah Enters M.O.U. with Hangshou Yuhang Economic-Technological Development Area
An MOU was signed between the Hangzhou District, World Trade Center Utah and BioUtah indicating a desire to…
-
Antibiotic-Resistant “Superbugs” – Public Health Crisis and Research Challenge
Antimicrobial Resistance (AMR) is a public health crisis, but developing new classes of antibiotics to combat drug resistant…
-
Red Tape Reduction: FDA Issues List of 510(k) Device Exemptions
On December 30, the FDA issued a notice (see the FDA’s Federal Register notice) that exempts certain class…
-
Congress Reconvenes: Drug Pricing, USMCA updates
Congress returned yesterday with a number of big ticket items on their plate, including drug pricing and the…
Call to Action
Post Category
- BioUtah COVID-19 Analysis
- BioUtah News
- Business Tools & Resources
- Call to Action
- chair
- COVID-19 Legislation
- COVID-19 Updates
- Economic Developments
- Events
- Events
- Feature
- Featured Members
- Federal News
- Funding
- Funding
- Guests Posts
- HHS/FDA & Other Regulatory
- HR
- Industry News
- Life Sciences Events
- Life Sciences Industry News
- Newsletters
- Non-chair
- Policy News
- Press Releases
- State News
- Utah's Life Sciences Companies
- Workplace Safety
Latest Posts
- Lumea Named Best New Biopsy Technology Solution in 2026 MedTech Breakthrough Awards
- Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
- BlueWind Medical Secures $47.8 Million Financing to Accelerate Commercialization of Revi® System
- PhotoPharmics Announces Last Patient Last Visit in Pivotal, Phase 3, Light for PD Clinical Trial; Company to Present Topline Data at World Parkinson Congress
- AFTER SUCCESSFUL FDA MEETING, CLENE FILING ACCELERATED APPROVAL NDA FOR ALS
